Monoclonal Antibody and Biosensor Core
Monoclonal Antibody and Biosensor Core
批准号:
7656437
负责人:
James E Crowe
金额:
$38.6万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-15 至 2009-02-28
关键词:
AloralAntibodiesAntigensBacillus anthracis sporeBacterial AdhesinsBindingBiological AssayBiosensorCell LineComplementCowpoxCytokine GeneDatabasesDetectionDevelopmentDiagnosisDiagnosticElementsHumanIRAK3 geneImmuneImmune responseImmunizationImmunohistochemistryInstitutionInterleukin-10Interleukin-4Macaca mulattaMonoclonal AntibodiesMusNaturePathogenesisPhage DisplayPoxviridaeProductionProtein FragmentProteinsRangeRattusReagentReceptor GeneRecombinantsRepliconResearchResearch Project GrantsRetroviridaeSECTM1 geneServicesSourceSystemTestingTherapeuticVacciniaWorkYersinia pestisanthrax protective factorconceptinterleukin-18 receptornovelprogramsrepositorysensorsuccessvaccine developmentvector
中文摘要
SERCEB的项目对单克隆有直接和预期的需求
英文摘要
The programs of the SERCEB have immediate and projected requirements for monoclonal
antibodies (mAbs) for studies of pathogenesis, immune response, vaccine development,
therapeutics and diagnostics. These reagents and bio-recognition elements will be vital to the
success of proposed research projects. The nature and source of the monoclonal antibodies
required will depend on the objective of the research program, ranging from murine monoclonal
antibodies for immunohistochemistry and detection to human or humanized mouse antibodies
for development of therapeutics. Broad expertise exists within the institutions of the SERCEB
in mAb development, testing and use. The spectrum of expertise in mAb development includes
human, mouse, humanized mouse, rhesus, and phage display human and mouse F abs and
ScFv. Finally, the antibodies will be deliverables that may have immediate application in
therapeutics and diagnostics. The proposed Core C is a distributed core that uses established
labs at several institutions to provide each of the needed services. The Core will provide all of
the biorecognition elements needed in the SERCEB and will develop them into new assays and
biosensors.
The core has four Specific Aims.
Aim 1. Generate human mAbs to poxvirus neutralization targets and anthrax protective
antigen.
Aim 2. Generate high-quality mAb reagents for SERCEB research programs.
Aim 3. Develop biosensors for diagnostics or detection of select agents using novel mAbs
available in the SERCEB
Aim 4. To develop a database and repository for mAbs within the SERCEB that can be
shared across institutions, to facilitate the other scientific programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Monoclonal Antibodies for Encephalitic Alphaviruses
-
批准号:10539155
-
项目类别:
-
资助金额:$85.81万
-
财政年份:2022
-
负责人:James E Crowe
-
依托单位:
Human Monoclonal Antibodies for Encephalitic Alphaviruses
-
批准号:10669266
-
项目类别:
-
资助金额:$81.03万
-
财政年份:2022
-
负责人:James E Crowe
-
依托单位:
Structure based design of trimer interface epitope focused universal influenza vaccines
-
批准号:10361516
-
项目类别:
-
资助金额:$122.11万
-
财政年份:2020
-
负责人:James E Crowe
-
依托单位:
Structure based design of trimer interface epitope focused universal influenza vaccines
-
批准号:10576343
-
项目类别:
-
资助金额:$121.34万
-
财政年份:2020
-
负责人:James E Crowe
-
依托单位:
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Virus Neutralization
-
批准号:10021075
-
项目类别:
-
资助金额:$62.84万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
-
批准号:10576280
-
项目类别:
-
资助金额:$246.43万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
-
批准号:10541163
-
项目类别:
-
资助金额:$70.33万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization
-
批准号:10669544
-
项目类别:
-
资助金额:$64.56万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization
-
批准号:10903692
-
项目类别:
-
资助金额:$64.56万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Project 2 - Vanderbilt University
-
批准号:10362732
-
项目类别:
-
资助金额:$80.23万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
-
批准号:10564151
-
项目类别:
-
资助金额:$246.43万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Project 2 - Vanderbilt University
-
批准号:10581502
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION
-
批准号:10706905
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Human neutralizing antibodies for Zika virus
-
批准号:9219776
-
项目类别:
-
资助金额:$132.79万
-
财政年份:2017
-
负责人:James E Crowe
-
依托单位:
Human neutralizing antibodies for Zika virus
-
批准号:10082297
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2017
-
负责人:James E Crowe
-
依托单位:
Structural and functional basis of ultra potent CHKV neutralization by human mAbs
-
批准号:8894218
-
项目类别:
-
资助金额:$76.18万
-
财政年份:2015
-
负责人:James E Crowe
-
依托单位:
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses
-
批准号:8814174
-
项目类别:
-
资助金额:$171.19万
-
财政年份:2015
-
负责人:James E Crowe
-
依托单位:
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses
-
批准号:10244879
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2015
-
负责人:James E Crowe
-
依托单位:
GENETIC & STRUCTURAL BASIS FOR INFLUENZA VIRUS NEUTRALIZATION
-
批准号:9570367
-
项目类别:
-
资助金额:$261.68万
-
财政年份:2014
-
负责人:James E Crowe
-
依托单位:
Hybrid Methods for Prediction and Design of Novel Human Influenza Antibodies
-
批准号:8919482
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2014
-
负责人:James E Crowe
-
依托单位:
海外基金